Both intracerebroventricular infusion and peripheral administration of anti-tau antibodies specific for N-terminal 25–30 epitopes are curative in P301S mice model of tauopathy, by preventing the brain atrophy and ameliorating the motor/sensorimotor functions (Yanamandra et al., 2013, 2015). The gene discussed is MAPT; the disease is tauopathy.